CapsoVision
CVCV · Stock Price
Historical price data
Overview
CapsoVision's mission is to advance gastrointestinal diagnostics through its proprietary, panoramic capsule endoscopy technology. The company has achieved significant milestones, including FDA clearance for patients as young as two years old and for remote ingestion, expanding access and convenience. Its strategy centers on leveraging its unique 360° imaging and cloud-based software platform to capture market share in the small bowel capsule endoscopy segment by offering superior diagnostic capabilities and a streamlined, cost-effective model for providers.
Technology Platform
A wire-free capsule endoscopy platform featuring a 360° panoramic viewing capsule with onboard data storage and a cloud-based software suite for remote video review and analysis.
Funding History
4Opportunities
Risk Factors
Competitive Landscape
Competes primarily against Medtronic's PillCam (axial view) and other international capsule systems. Key differentiators are its 360° panoramic imaging, which may improve diagnostic yield, and its completely wire-free, cloud-based patient experience and provider workflow.
Competitors
Company Timeline
Founded in United States
Series B: $15.0M
Series C: $30.0M
IPO — $20.0M